JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹16 Cr | ₹17 Cr | ₹20 Cr | ₹17 Cr | ₹17 Cr |
What is the latest Contingent Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹16 Cr |
Mar2024 | ₹17 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹17 Cr |
Mar2021 | ₹17 Cr |
How is Contingent Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹16 Cr | -0.45 | |
Mar2024 | ₹17 Cr | -15.25 | |
Mar2023 | ₹20 Cr | 17.75 | |
Mar2022 | ₹17 Cr | -0.19 | |
Mar2021 | ₹17 Cr | - |
Compare Contingent Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹595.1 Cr | 4.9% | 18.2% | 58.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,017.0 Cr | -0.2% | -0.5% | 10.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,867.0 Cr | 4% | 4.8% | 50.5% | Stock Analytics | |
CIPLA | ₹122,451.0 Cr | 0.4% | 3.1% | 1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,620.0 Cr | 5.9% | 9.1% | 23% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,572.0 Cr | -4.8% | 2.2% | 2.9% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | 4.9% |
18.2% |
58.6% |
SENSEX | 2% |
2.8% |
6.4% |
You may also like the below Video Courses